Technical 200dma bullish cross, page-68

I agree, a lot needs to go right, but CardieX is also entering some truly massive markets with disruptive, patented technology.

think of this statistic alone, and some creative calculations.

Wearables -

estimated global market size US $20.5B in 2022, with 4.8% household penetration.

Hypertension effects 50% of all US citizens. Let’s guess at 70% households. Let’s say rest of the world a bit healthier on average than US, so 50% all Global households have an adult with hypertension.

So, if 2% of homes with hypertension purchase a wearable with CardieX technology , that is 1% of total homes, or 20.8% of existing homes with wearables ( they upgrade ! ). So we have US$4.2B in sales of wearables using CardieX technology. Average revenue per user with a wearable is USD $43, 100m units.

How much of the USD do we get per sale on a licence fee ( if 100% were licensed sales, ignoring that we are launching our own wearable as well ) . I don’t know, but let’s guess at .50c. So USD $50M per year in licence fees, that virtually goes straight to the bottom line.

Then , we convince another 2% of homes with hypertension ( total of 4% of homes with hypertension) to enter wearables market. License fees jump to $100m a year.

Let’s say 900m SOI and $75M net earnings from licence fees. SP of $1.50 would be PE of 18.

And this is wearables alone.

Household Blood Pressure Monitor market estimated to be USD $1.4B in 2022. What share of that will we get?

lots of variables here I know, and the astute among you will probably find holes in this logic.
However, my key point to make is the market segment and target audience is huge.
Actually, Not that much needs to go right !